Inogen director granted 28,081 restricted shares

Sahney Mira Kirti reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Sahney Mira Kirti reported acquisition or exercise transactions in this Form 4 filing.

Inogen director Mira Kirti Sahney received an equity grant of 28,081 shares of Common Stock through a restricted stock unit award. The grant date was June 5, 2026.

The award vests on the earlier of the one-year anniversary of the grant or the day prior to the next Annual Meeting of stockholders, subject to her continued service. After this grant, she directly holds 67,805 shares of Inogen stock. This is compensation-related, not an open-market purchase.

Insider Trade Summary

Grant/Award: 28,081 shares

Grant/Award 1 txn

Insider Sahney Mira Kirti

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	28,081	$0.00	$0.00

Holdings After Transaction: Common Stock — 67,805 shares (Direct)

Footnotes (1)

1. F1. The reported shares were acquired pursuant to a restricted stock unit award. Subject to the reporting person's continued service, the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant.

Key Figures

RSU grant size: 28,081 shares Transaction price per share: $0.0000 per share Holdings after grant: 67,805 shares +2 more

5 metrics

RSU grant size 28,081 shares Restricted stock unit award of Common Stock

Transaction price per share $0.0000 per share Grant/award acquisition, non-market transaction

Holdings after grant 67,805 shares Total Common Stock directly owned after transaction

Transaction date June 5, 2026 Grant date of restricted stock unit award

Vesting condition Earlier of 1-year or pre-Annual Meeting Subject to continued service under RSU terms

Key Terms

restricted stock unit award, Common Stock, Annual Meeting

3 terms

restricted stock unit award financial

"The reported shares were acquired pursuant to a restricted stock unit award."

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

Common Stock financial

"security_title: Common Stock in the non-derivative transaction."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Annual Meeting financial

"the day prior to the date of the Annual Meeting of the Issuer's stockholders"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Inogen (INGN) director Mira Kirti Sahney report in this Form 4?

She reported receiving a grant of 28,081 shares of Inogen Common Stock via a restricted stock unit award. This equity compensation increased her direct holdings to 67,805 shares, reflecting a routine board-related award rather than an open-market stock purchase.

How many Inogen (INGN) shares did Mira Kirti Sahney acquire in this grant?

She acquired 28,081 shares of Inogen Common Stock through a restricted stock unit award. The transaction price per share is listed as $0.0000, indicating a compensation grant instead of a market transaction, with no cash paid per share by the director.

When do Mira Kirti Sahney’s new Inogen (INGN) restricted stock units vest?

The restricted stock unit award vests on the earlier of the one-year anniversary of the June 5, 2026 grant date or the day prior to Inogen’s next Annual Meeting. Vesting is conditioned on her continued service as specified in the award’s terms.

What are Mira Kirti Sahney’s Inogen (INGN) holdings after this Form 4 transaction?

Following the grant, she directly holds 67,805 shares of Inogen Common Stock. This total includes the 28,081 shares acquired through the restricted stock unit award, as reported in the Form 4, and reflects her post-transaction direct ownership position.

Was this Inogen (INGN) Form 4 a stock purchase or a compensation grant?

It reflects a compensation grant, not a market purchase. The filing shows transaction code "A" for a grant or award and a transaction price of $0.0000 per share, indicating restricted stock units awarded for service rather than shares bought in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/09/2026 - 04:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sahney Mira Kirti

(Last) (First) (Middle)

C/O INOGEN, INC.

500 CUMMINGS CENTER, SUITE 2800

(Street)

BEVERLY MASSACHUSETTS 01915

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inogen Inc [ INGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		A		28,081(1)	A	$0	67,805	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported shares were acquired pursuant to a restricted stock unit award. Subject to the reporting person's continued service, the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant.

	/s/ Mary Wright, as Attorney-in-Fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)